Citation 158674

BUENING,MK: CHANG,RL: HUANG,M: FORTNER,JG: WOOD,AW: CONNEY,AH:. (1981). ACTIVATION AND INHIBITION OF BENZO(A)PYRENE AND AFLATOXIN B1 METABOLISM IN HUMAN LIVER MICROSOMES BY NATURALLY OCCURRING FLAVONOIDS.. 41()

Citation Details

Title	ACTIVATION AND INHIBITION OF BENZO(A)PYRENE AND AFLATOXIN B1 METABOLISM IN HUMAN LIVER MICROSOMES BY NATURALLY OCCURRING FLAVONOIDS.
Authors	BUENING,MK: CHANG,RL: HUANG,M: FORTNER,JG: WOOD,AW: CONNEY,AH:
Year	1981
Volume	41
Issue

Summary

Year: 1981

Journal: Unknown

Organisms and Their Experiments (14)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	BENZPYRENE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	APIGENIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	BENZPYRENE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	CHRYSIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	BENZPYRENE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	FISETIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	BENZPYRENE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	FLAVANONE	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTISTREPTOLYSIN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FLAVONE	ACTIVE
2	CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	INACTIVE
3	CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	FLAVONE	EQUIVOCAL

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	BENZPYRENE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	GALANGIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	BENZPYRENE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	HESPERETIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	BENZPYRENE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	KAEMPFEROL	ACTIVE
2	CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	BENZPYRENE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MORIN	STRONG ACTIVITY
2	CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MORIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	BENZPYRENE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MYRICETIN	STRONG ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	BENZPYRENE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	NARINGENIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTISTREPTOLYSIN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NOBILETIN	STRONG ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	BENZPYRENE HYDROXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	QUERCETIN	ACTIVE
2	CYTOCHROME C REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	QUERCETIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTISTREPTOLYSIN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TANGERETIN	STRONG ACTIVITY

Show SPARQL Queries (1)